OptionsHouse

Options Trading News

December 20, 2012  Thu 7:28 AM CT

ILMN: SEE CHART GET CHAIN FIND STRATEGIES
Roche Comes Back to the Table

Illumina has been a target of M&A chatter before, and it's back in the headlines today. Swiss newspaper L'Agefi reported that Roche Holding may try to buy the company for $66 a share. ILMN, which closed at $52.17 yesterday, is up 7 percent before the bell on my tradeMONSTER platform.

Motorola Deal Lifts Arris Shares

Arris Group agreed to purchase Motorola Home from Google for $2.35 billion in cash and stock. The deal will also increase ARRS's patent portfolio and give it access to a range of Motorola Mobility's intellectual property. ARRS rose 7 percent in early trading.

Allscripts Down on New Direction

Allscripts Healthcare decided not to sell itself and will instead try to rebuild under new leadership. It fired old CEO and gave the reins to a board member who formerly ran competitor Cerner. The change of direction is sending MDRX down by 16 percent in the premarket.

Amicus Plunges on Drug-Trial Data

Amicus Therapeutics said that its migalastat HCl drug candidate for the treatment of Fabry disease failed to meet goals in a key Phase 3 trial. FOLD craters 45 percent on the news.
Share this article with your friends


Related Stories

ILMN

Trader sees Illumina on solid ground

January 28, 2016

The genetic-analysis company is scheduled to report earnings early next week, and one large trader apparently believes that downside potential will be limited.

OptionsHouse

Premium Services

Upcoming Webinar:

Using Options For Income

http://bit.ly/1nY1OKA

Jon Najarian and Adam Mesh of Options Wealth Machine discuss a detailed strategy utilizing credit spreads to generate income, and how any level of trader can use this simple trading technique.

Education & Strategy

Sweet Spot Exceptions

As discussed last week, when using the Stock Replacement Strategy to replace a stock position to trade direction, we want to use an option that has very similar characteristics to the stock. We talked about using the deep in-the-money, 80 to 85 delta option that is similar in the Greeks and has relatively little extrinsic value which tends to work against us in stock directional trading.

View more education articles »